This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
Go
Reset
Send Date
Subject
Created Date
ID
Asc
Desc
AUA-IBCG Bladder Cancer Forum: Debating the Future of Bladder Cancer Care
Sent on 22 May 2026
Emerging Strategies in NMIBC from AUA 2026
Sent on 19 May 2026
AUA 2026 Advances in NMIBC Treatment and Risk Stratification
Sent on 17 May 2026
AUA 2026 Updates in MIBC and Advanced Urothelial Cancer
Sent on 17 May 2026
AUA 2026 Highlights Evolving Strategies in Prostate Cancer Care
Sent on 16 May 2026
AUA 2026 Updates in Kidney-Sparing and Bladder Cancer Strategies
Sent on 16 May 2026
AUA 2026 Plenary Headlines: Durvalumab (POTOMAC) and Pembrolizumab Combined with BCG in High-Risk NMIBC
Sent on 16 May 2026
American Urological Association (AUA) 2026 Practice-Changing, Paradigm-Shifting Clinical Trials in Urology and NMIBC Highlights
Sent on 15 May 2026
Key Bladder and Prostate Cancer Data to Watch at AUA 2026
Sent on 13 May 2026
The AUA - IBCG Bladder Cancer Forum - Case-Based Debates on the Management of Bladder Cancer
Sent on 02 May 2023
AUA 2023 Highlights from the Society of Urologic Oncology Session at the AUA
Sent on 01 May 2023
AUA Guidelines Update on UTUC, Bladder Cancer Epidemiology, and Muscle Invasive Treatment Options
Sent on 30 April 2023
Highlights from AUA 2023 on Non-Invasive Bladder Cancer Treatment
Sent on 29 April 2023
AUA 2023 Advancements in Prostate Cancer Treatment: Marker Detection, Radiation Therapy, and Drug Therapy
Sent on 29 April 2023
AUA Guidelines for Early Detection of Prostate Cancer and Highlights in Advanced Prostate Cancer
Sent on 28 April 2023
What to Expect from the Upcoming 2023 American Urological Association Annual Meeting
Sent on 23 April 2023
Highlights in Bladder and Kidney Cancer Featuring the Society of Urologic Oncology (SUO) Sessions from the American Urological Association Annual Meeting (AUA)
Sent on 19 May 2022
Featuring the IBCG Bladder Cancer Forum from the 2022 American Urological Association Annual Meeting (AUA)
Sent on 18 May 2022
Transforming the Paradigm for Low Grade UTUC
Sent on 17 May 2022
Late Breaking Abstracts in Prostate Cancer and Highlights in Localized and Advanced Disease from the American Urological Association Annual Meeting (AUA)
Sent on 17 May 2022
AUA Guidelines in Localized Prostate Cancer and Advanced Prostate Cancer Highlights from the American Urological Association Annual Meeting (AUA)
Sent on 15 May 2022
The Optimal Multidisciplinary Team in 2022 and Prostate Cancer Highlights from the American Urological Association Annual Meeting (AUA)
Sent on 14 May 2022
Plenary Presentations in GU Malignancies and Highlights from Day 1 of the 2022 American Urological Association Annual Meeting (AUA)
Sent on 13 May 2022
Looking Forward to AUA 2022 - What to Expect in Prostate, Kidney, and Bladder Cancer
Sent on 09 May 2022
Display #
5
10
15
20
25
30
50
100
Results 1 - 24 out of 24
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free